Dr. Maria Luisa Calabrò, Biologist

  • Role of the microenvironment in the pathogenesis of virus-induced lymphoma
  • Relevance of epithelial-mesenchymal transition (EMT) in highly aggressive tumors

Prof. Vincenzo Ciminale, MD

  • Harnessing redox homeostasis and cell death pathways for treatment of T-cell leukemia

Dr. Luigi Corti, MD

  • Identification of new biomarkers of radiosensitivity/resistance for patient stratification and personalized radiotherapy treatment planning

Prof. Anita De Rossi, PhD

  • Mechanisms promoting Epstein Barr Virus (EBV)-driven  malignancies
  • New approaches for the diagnosis and monitoring of tumors: telomere/telomerase complex

Dr. Annarosa Del Mistro, MD

  • HPV testing and novel biomarkers in prevention and diagnosis of cervical and oropharyngeal HPV-driven carcinomas

Dr. Stefano Indraccolo, MD

  • Metabolic adaptation of tumors to anti-angiogenetic therapy

Dr. Erich Piovan, MD, PhD

  • Targeting de-regulated signalling pathways in T cell acute lymphoblastic leukemia (T-ALL)

Dr. Daniela Saggioro, PhD

  • Circulating cell free DNA (CfDNA) as a new tool to monitor patients with Barrett’s esophagus (BE) or esophageal cancer (EC). The application of cfDNA and NGS

Dr. Valeria Tosello, Biologist

  • Molecular pathogenesis of T-cell acute lymphoblastic leukaemia and lymphoma